|
May 2
|
The Top 3 Penny Stocks to Buy in April 2024
|
|
Apr 25
|
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
|
|
Apr 24
|
3 Red-Hot Biotech Rockets Blasting Off in 2024
|
|
Apr 11
|
Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future
|
|
Apr 3
|
Geron to Participate at Upcoming Investor Conferences in April
|
|
Apr 1
|
5 FDA decisions to watch in the second quarter
|
|
Mar 21
|
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
|
|
Mar 19
|
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
|
|
Mar 15
|
Geron, Madrigal Pharmaceuticals jump on good news from FDA
|
|
Mar 15
|
Stocks to Watch Friday: Adobe, Ulta, Fisker
|
|
Mar 15
|
Geron (GERN) Gets ODAC Votes for Blood Disorder Drug, Shares Up
|
|
Mar 14
|
Geron Stock Is Soaring After Hours: What's Going On?
|
|
Mar 14
|
Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
|
|
Mar 14
|
UPDATE 3-Geron's blood disorder drug gets FDA advisers' backing
|
|
Mar 13
|
Implied Volatility Surging for Geron (GERN) Stock Options
|
|
Mar 12
|
UPDATE 3-US FDA staff raises concerns on Geron's blood disorder drug
|
|
Mar 1
|
Geron Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
|
Feb 29
|
Geron Corporation (NASDAQ:GERN) Q4 2023 Earnings Call Transcript
|
|
Feb 28
|
Geron (GERN) Q4 2023 Earnings Call Transcript
|
|
Feb 28
|
Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
|